Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
Clinical trial NCT04619316 · UNKNOWN
Trial details
- NCT number
- NCT04619316
- Sponsor
- University Hospital, Essen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2024-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.